<?xml version="1.0" encoding="UTF-8"?>

<ODM xmlns="http://www.cdisc.org/ns/odm/v1.3" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:nciodm="http://ncicb.nci.nih.gov/xml/odm/EVS/CDISC" FileType="Snapshot" FileOID="CDISC_CT.Protocol.2021-12-17" Granularity="Metadata" CreationDateTime="2021-12-17T11:05:38" AsOfDateTime="2021-12-17T00:00:00" ODMVersion="1.3.2" Originator="CDISC XML Technologies Team (Terminology2ODM converter)" SourceSystem="NCI Thesaurus" SourceSystemVersion="2021-12-17" nciodm:Context="Other" nciodm:ControlledTerminologyVersion="1.2.0">
    <Study OID="CDISC_CT.Protocol.2021-12-17">
        <GlobalVariables>
            <StudyName>CDISC Protocol Controlled Terminology</StudyName>
            <StudyDescription>CDISC Protocol Controlled Terminology, 2021-12-17</StudyDescription>
            <ProtocolName>CDISC Protocol Controlled Terminology</ProtocolName>
        </GlobalVariables>
        <MetaDataVersion OID="CDISC_CT_MetaDataVersion.Protocol.2021-12-17" Name="CDISC Protocol Controlled Terminology" Description="CDISC Protocol Controlled Terminology, 2021-12-17">
            <CodeList OID="CL.C179587.Biological Sample Attribute Terminology" Name="Biological Sample Attribute Terminology" DataType="text" nciodm:ExtCodeID="C179587">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the biological sample.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Biological Sample Accountability" nciodm:ExtCodeID="C179744">
                    <nciodm:CDISCDefinition>The activities describing the documentation of the storage, inventory tracking, and disposition of the biological sample.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Handling Accountability Record</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Collection Method" nciodm:ExtCodeID="C70700">
                    <nciodm:CDISCDefinition>A description of the methodology by which biological material is obtained from a subject.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Collection Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Collection Timing" nciodm:ExtCodeID="C178869">
                    <nciodm:CDISCDefinition>A description of the timing for the collection of a biological sample, in relation to a study-specific event or time period.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Collection Time</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Collection" nciodm:ExtCodeID="C70945">
                    <nciodm:CDISCDefinition>The activities describing biological sample collection, such as specimen type, timing and methodology.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Collection</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Handling" nciodm:ExtCodeID="C179745">
                    <nciodm:CDISCSynonym>Biospecimen Handling</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Handling of Biological Samples</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Handling of Biological Specimens</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A description of the management of biological sample handling, including methods of collection, processing, shipping, and storage.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Handling</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Preparation" nciodm:ExtCodeID="C179746">
                    <nciodm:CDISCDefinition>The activities describing how the biological sample is made ready for storage, processing, and/or analysis.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Preparation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Retention" nciodm:ExtCodeID="C181231">
                    <nciodm:CDISCSynonym>Biospecimen Retention</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description as to whether and/or how biological samples are retained for research purposes.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biological Sample Retention Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Shipping" nciodm:ExtCodeID="C179747">
                    <nciodm:CDISCSynonym>Biological Sample Shipment</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Biological Sample Transport</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The activities describing the logistical considerations for transporting a biological sample from the sender to the receiver.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Shipping</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biological Sample Storage" nciodm:ExtCodeID="C179748">
                    <nciodm:CDISCDefinition>The activities describing the physical or environmental conditions under which the biological sample is maintained.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Storage</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Biological Sample Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Biological Sample Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Biological Sample Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C142191.Clinical Study Attribute Terminology" Name="Clinical Study Attribute Terminology" DataType="text" nciodm:ExtCodeID="C142191">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the clinical study entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Primary Clinical Study Sponsor" nciodm:ExtCodeID="C70794">
                    <nciodm:CDISCDefinition>The individual, organization, group or other legal person taking responsibility for securing the arrangements to initiate and/or manage a study (including arrangements to ensure that the study design meets appropriate standards and to ensure appropriate conduct and reporting). In commercial trials, the primary sponsor is normally the main applicant for regulatory authorization to begin the study. It may or may not be the main funder. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Clinical Study Sponsor" nciodm:ExtCodeID="C70795">
                    <nciodm:CDISCDefinition>Additional individuals, organizations or other legal persons, if any, that have agreed with the primary sponsor to take on responsibilities of sponsorship. A secondary sponsor may have agreed to take on all the responsibilities of sponsorship jointly with the primary sponsor; or to form a group with the primary sponsor in which the responsibilities of sponsorship are allocated among the members of the group; or to act as the sponsor's legal representative in relation to some or all of the study sites; or to take responsibility for the accuracy of study registration information submitted.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Activity" nciodm:ExtCodeID="C71473">
                    <nciodm:CDISCDefinition>An action, undertaking, or event, which is anticipated to be performed or observed, or was performed or observed, according to the study protocol during the execution of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Activity</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Rationale" nciodm:ExtCodeID="C94122">
                    <nciodm:CDISCSynonym>Study Purpose</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A statement describing the overall rationale of the study. This field describes the contribution of this study to product development, i.e., what knowledge is being contributed from the conduct of this study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Purpose Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Schematic Diagram" nciodm:ExtCodeID="C93682">
                    <nciodm:CDISCSynonym>Study Schema</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A diagram that outlines the decision points (e.g. randomization, response evaluation) that define the different paths a participant could take through the study. This is typically a block diagram and may include epochs, timing of randomization, treatment arms, and duration of treatments.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Schematic</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Type" nciodm:ExtCodeID="C142175">
                    <nciodm:CDISCSynonym>Study Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The nature of the investigation for which study information is being collected. (After clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Clinical Study Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Clinical Study Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Clinical Study Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C139020.Clinical Trial Attribute Terminology" Name="Clinical Trial Attribute Terminology" DataType="text" nciodm:ExtCodeID="C139020">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the clinical trial entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Country of Recruitment" nciodm:ExtCodeID="C139170">
                    <nciodm:CDISCDefinition>The country in which participants are located when enrolling in a trial or study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Country of Recruitment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Date of First Enrollment" nciodm:ExtCodeID="C139171">
                    <nciodm:CDISCDefinition>Date or date and time of first subject enrollment into a study, as verifiable by a convention that is consistent with authoritative regulatory criteria. Compare with study start. [Modified from ICH E3] (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Date of First Enrollment into Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Exclusion Criteria" nciodm:ExtCodeID="C25370">
                    <nciodm:CDISCDefinition>List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Exclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Inclusion Criteria" nciodm:ExtCodeID="C25532">
                    <nciodm:CDISCDefinition>The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Inclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Planned Trial Duration" nciodm:ExtCodeID="C127796">
                    <nciodm:CDISCSynonym>Planned Trial Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The approximate period of time over which the clinical trial is expected to occur.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Trial Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Sponsor Name" nciodm:ExtCodeID="C139168">
                    <nciodm:CDISCDefinition>The name of the entity that is considered the primary sponsor for the trial or study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Study Sponsor Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Sponsor Name" nciodm:ExtCodeID="C139169">
                    <nciodm:CDISCDefinition>The name of the entity that is considered the secondary sponsor for the trial or study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Study Sponsor Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Source of Monetary or Material Support for Study" nciodm:ExtCodeID="C139167">
                    <nciodm:CDISCDefinition>The major organizations providing monetary or material support for the conduct of the trial, including, but not limited to, funding, design, implementation, data analysis and reporting. (EudraCT)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Source of Monetary or Material Support for Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Target Sample Size" nciodm:ExtCodeID="C139172">
                    <nciodm:CDISCDefinition>The total number of planned participants in a study or trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Target Sample Size</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Therapeutic Area" nciodm:ExtCodeID="C101302">
                    <nciodm:CDISCSynonym>Therapeutic Area</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A knowledge field that focuses on research and development of specific treatments for diseases and pathologic findings, as well as prevention of conditions that negatively impact the health of an individual. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Therapeutic Area</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Design" nciodm:ExtCodeID="C15787">
                    <nciodm:CDISCDefinition>The detailed planning of a study of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trials Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Disease/Condition Indication" nciodm:ExtCodeID="C112038">
                    <nciodm:CDISCSynonym>Trial Disease/Condition Indication</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The condition, disease or disorder that the clinical trial is intended to investigate or address.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Indication</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Intent" nciodm:ExtCodeID="C49652">
                    <nciodm:CDISCSynonym>Trial Intent Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned purpose of the therapy, device, or agent under study in the clinical trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study by Intent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Phase" nciodm:ExtCodeID="C48281">
                    <nciodm:CDISCSynonym>Trial Phase Classification</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any defined stage in the lifecycle of a clinical trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Phase</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Primary Objective" nciodm:ExtCodeID="C85826">
                    <nciodm:CDISCSynonym>Trial Primary Objective</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The principal purpose of the trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Primary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Registration Indicator" nciodm:ExtCodeID="C139166">
                    <nciodm:CDISCDefinition>An indication as to whether the clinical trial has been registered with a trial registry system.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Registration Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Secondary Objective" nciodm:ExtCodeID="C85827">
                    <nciodm:CDISCSynonym>Trial Secondary Objective</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The auxiliary purpose of the trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Secondary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Site" nciodm:ExtCodeID="C85838">
                    <nciodm:CDISCSynonym>Investigative Site</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Investigator Site</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any healthcare organization, institution, facility or provider directly involved in conducting or facilitating a particular clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Site</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Type" nciodm:ExtCodeID="C49660">
                    <nciodm:CDISCSynonym>Trial Scope</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The nature of the interventional study for which information is being collected.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Clinical Trial Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Clinical Trial Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Clinical Trial Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C170440.Endpoint Attribute Terminology" Name="Endpoint Attribute Terminology" DataType="text" nciodm:ExtCodeID="C170440">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the endpoint entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Endpoint Type" nciodm:ExtCodeID="C170557">
                    <nciodm:CDISCDefinition>A characterization or classification of the defined variable intended to reflect an outcome measure of interest that is statistically analyzed to address a particular research question.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Endpoint Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Justification for Endpoint" nciodm:ExtCodeID="C170558">
                    <nciodm:CDISCDefinition>The rationale or explanation for why each study endpoint was chosen.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Justification for Study Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Endpoint Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Endpoint Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Endpoint Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C170441.Endpoint Type Value Set Terminology" Name="Endpoint Type Value Set Terminology" DataType="text" nciodm:ExtCodeID="C170441">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the type of endpoint for the study.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Composite Endpoint" nciodm:ExtCodeID="C170561">
                    <nciodm:CDISCSynonym>Combined Endpoint</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Endpoint(s) constructed from two or more endpoints that represents an overall clinically relevant measure of clinical benefit.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Composite Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Direct Endpoint" nciodm:ExtCodeID="C170560">
                    <nciodm:CDISCDefinition>Endpoint(s) used in clinical studies to directly measure how a patient feels, functions, or survives. These endpoint(s) in themselves represent or characterize the clinical outcome of interest. (FDA: https://www.fda.gov/media/84987/download)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Direct Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Exploratory Endpoint" nciodm:ExtCodeID="C170559">
                    <nciodm:CDISCDefinition>Endpoint(s) that may include clinically important events that are expected to occur too infrequently to show a treatment effect or endpoints that for other reasons are thought to be less likely to show an effect but are included to explore new hypotheses. (After FDA-NIH Protocol Template)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Exploratory Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Endpoint" nciodm:ExtCodeID="C94496">
                    <nciodm:CDISCDefinition>Endpoint(s) of greatest importance that is the basis for concluding whether the study met its objective(s) and provides a clinically relevant, valid, and reliable measure of the primary objective(s). (After FDA-NIH Protocol Template)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Endpoint" nciodm:ExtCodeID="C139173">
                    <nciodm:CDISCDefinition>Endpoint(s) that may provide supportive information about the effect of the study intervention(s) on the primary endpoint or demonstrate additional effects on the disease or condition. (After FDA-NIH Protocol Template)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Surrogate Endpoint" nciodm:ExtCodeID="C68772">
                    <nciodm:CDISCDefinition>Endpoint(s) used in clinical studies as a substitute for a direct measure of how a patient feels, functions, or survives. A surrogate endpoint is expected to predict clinical benefit or harm based on epidemiologic, therapeutic, pathophysiologic, or other scientific evidence. A surrogate endpoint does not measure the clinical benefit of primary interest in and of itself. (After NIH-FDA BEST (Biomarkers, Endpoints, and other Tools) Resource, https://www.ncbi.nlm.nih.gov/books/NBK338448/)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Surrogate Endpoint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Endpoint Type Value Set Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Endpoint Type Value Set Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Endpoint Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C184334.Informed Consent Attribute Terminology" Name="Informed Consent Attribute Terminology" DataType="text" nciodm:ExtCodeID="C184334">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the informed consent.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Assent" nciodm:ExtCodeID="C161418">
                    <nciodm:CDISCSynonym>Informed Assent</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Assent given by a minor or adult who is unable to give informed consent on their own behalf, to participate in a clinical trial. Assent must be accompanied by consent from a parent or legal guardian for full participation in the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Informed Assent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Informed Consent Form" nciodm:ExtCodeID="C16468">
                    <nciodm:CDISCSynonym>Informed Consent Document</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A formal document explaining the potential risks and benefits of participation in a study and the rights and responsibilities of the parties involved, in a manner that is understandable to the subject or their legally authorized representative.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Consent Form</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Informed Consent Process" nciodm:ExtCodeID="C184390">
                    <nciodm:CDISCSynonym>Informed Consent Procedure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The procedure by which informed consent is obtained and documented by means of a written, signed, and dated informed consent form. This process may include obtaining assent from subjects with legally authorized representatives. (ICH GCP)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Informed Consent Process</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Informed Consent Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Informed Consent Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Informed Consent Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C177906.Ingredient Attribute Terminology" Name="Ingredient Attribute Terminology" DataType="text" nciodm:ExtCodeID="C177906">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the ingredient.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Drug Product Component" nciodm:ExtCodeID="C177929">
                    <nciodm:CDISCSynonym>Component</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any ingredient intended for use in the manufacture of a drug product, including those that may not appear in such drug product. (FDA 21 CFR 314.3(a))</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Drug Product Component</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Ingredient Type" nciodm:ExtCodeID="C177928">
                    <nciodm:CDISCDefinition>A characterization or classification of the component that constitutes a part of a compound or mixture.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Ingredient Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Ingredient Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Ingredient Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Ingredient Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C177907.Ingredient Type Value Set Terminology" Name="Ingredient Type Value Set Terminology" DataType="text" nciodm:ExtCodeID="C177907">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the identification of the kind of ingredient.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Active Ingredient" nciodm:ExtCodeID="C82533">
                    <nciodm:CDISCDefinition>Any component of a study product intended to exert pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body of humans or other animals. (After 21 CFR 210.3(b)(7))</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Active Ingredient</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Inactive Ingredient" nciodm:ExtCodeID="C42637">
                    <nciodm:CDISCSynonym>Inert Ingredient</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any component of a study product other than an active ingredient. (After FDA 21 CFR 210.3(b)(8))</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmaceutical Excipient</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Ingredient Type Value Set Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Ingredient Type Value Set Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Ingredient Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C177905.Intervention Attribute Terminology" Name="Intervention Attribute Terminology" DataType="text" nciodm:ExtCodeID="C177905">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the intervention.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Intervention Description" nciodm:ExtCodeID="C177931">
                    <nciodm:CDISCDefinition>The textual representation of the study intervention.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Name" nciodm:ExtCodeID="C177930">
                    <nciodm:CDISCDefinition>The identifying name for the study intervention.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Type" nciodm:ExtCodeID="C98747">
                    <nciodm:CDISCSynonym>Intervention Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The kind of product or procedure studied in a trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Intervention Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Intervention Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Intervention Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C99076.INTMODEL" Name="Intervention Model Response" DataType="text" nciodm:ExtCodeID="C99076" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the trial design developed to compare treatment groups.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="CROSS-OVER" nciodm:ExtCodeID="C82637">
                    <nciodm:CDISCDefinition>Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Crossover Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FACTORIAL" nciodm:ExtCodeID="C82638">
                    <nciodm:CDISCDefinition>Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Factorial Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PARALLEL" nciodm:ExtCodeID="C82639">
                    <nciodm:CDISCDefinition>Participants are assigned to one of two or more treatment groups in parallel for the duration of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Parallel Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SEQUENTIAL" nciodm:ExtCodeID="C142568">
                    <nciodm:CDISCDefinition>Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Group Sequential Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SINGLE GROUP" nciodm:ExtCodeID="C82640">
                    <nciodm:CDISCDefinition>All trial participants are assigned to a single treatment group for the duration of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Single Group Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>INTMODEL</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Intervention Model Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Intervention Model Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C99078.INTTYPE" Name="Intervention Type Response" DataType="text" nciodm:ExtCodeID="C99078" nciodm:CodeListExtensible="No">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the kind of product or procedure studied in a trial.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="BEHAVIORAL THERAPY" nciodm:ExtCodeID="C15184">
                    <nciodm:CDISCDefinition>A technique used to change the behavior of a subject (e.g., psychotherapy, lifestyle counseling, or hypnosis).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Behavioral Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BIOLOGIC" nciodm:ExtCodeID="C307">
                    <nciodm:CDISCDefinition>A substance made from living organisms or things they produce, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biological Agent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DEVICE" nciodm:ExtCodeID="C16830">
                    <nciodm:CDISCSynonym>Medical Device</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for, one or more specific medical purpose(s).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Medical Device</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DIETARY SUPPLEMENT" nciodm:ExtCodeID="C1505">
                    <nciodm:CDISCDefinition>Preparations containing ingredient(s) intended to supplement the diet.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dietary Supplement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DRUG" nciodm:ExtCodeID="C1909">
                    <nciodm:CDISCDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacologic Substance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="GENETIC" nciodm:ExtCodeID="C15238">
                    <nciodm:CDISCSynonym>Gene Therapy</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Introduction of genetic material into cells in order to correct or treat an inherited or acquired disease.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Gene Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OTHER" nciodm:ExtCodeID="C17649">
                    <nciodm:CDISCSynonym>Other</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Different than the one(s) previously specified or mentioned. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Other</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PROCEDURE" nciodm:ExtCodeID="C98769">
                    <nciodm:CDISCSynonym>Medical Procedure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any activity performed by manual and/or instrumental means for the purpose of diagnosis, assessment, therapy, prevention, or palliative care.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Physical Medical Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RADIATION" nciodm:ExtCodeID="C15313">
                    <nciodm:CDISCSynonym>Radiation Therapy</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Radiotherapy</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Use of targeted or whole body radiation to treat a disease.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Radiation Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>INTTYPE</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Intervention Type Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Intervention Type Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C66742.NY" Name="No Yes Response" DataType="text" nciodm:ExtCodeID="C66742" nciodm:CodeListExtensible="No">
                <Description>
                    <TranslatedText xml:lang="en">A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="N" nciodm:ExtCodeID="C49487">
                    <nciodm:CDISCSynonym>No</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The non-affirmative response to a question. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>No</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NA" nciodm:ExtCodeID="C48660">
                    <nciodm:CDISCSynonym>NA</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Not Applicable</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Determination of a value is not relevant in the current context. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Not Applicable</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="U" nciodm:ExtCodeID="C17998">
                    <nciodm:CDISCSynonym>U</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>UNK</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Unknown</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Not known, not observed, not recorded, or refused. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Unknown</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Y" nciodm:ExtCodeID="C49488">
                    <nciodm:CDISCSynonym>Yes</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The affirmative response to a question. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Yes</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>NY</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>No Yes Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C127259.OBSSMO" Name="Observational Study Model" DataType="text" nciodm:ExtCodeID="C127259" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the trial design for observational studies.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="CASE CONTROL" nciodm:ExtCodeID="C15197">
                    <nciodm:CDISCDefinition>A study that compares groups of people with generally similar characteristics, those with the condition under study (case) and those without the condition under study (control).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Case-Control Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CASE CROSSOVER" nciodm:ExtCodeID="C127779">
                    <nciodm:CDISCDefinition>A study in which the subject characteristics of the case, immediately prior to disease onset (sometimes called the hazard period), are compared to characteristics of same case at a prior time (i.e., control period). (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Case-Crossover Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CASE ONLY" nciodm:ExtCodeID="C15362">
                    <nciodm:CDISCDefinition>A study in which the subject with the condition under study (the case) is compared against a theoretical/historical model of distribution that serves as a control.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Case Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="COHORT" nciodm:ExtCodeID="C15208">
                    <nciodm:CDISCDefinition>A study in which subjects are grouped based on a predefined personal or administrative characteristic.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Cohort Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ECOLOGIC OR COMMUNITY" nciodm:ExtCodeID="C127780">
                    <nciodm:CDISCDefinition>A study in which geographically distinct study populations are compared with respect to a particular outcome.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Ecologic or Community Based Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FAMILY BASED" nciodm:ExtCodeID="C15407">
                    <nciodm:CDISCDefinition>A study in which related or non-related family members are compared with respect to a particular outcome.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Family Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>OBSSMO</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Observational Study Model</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Observational Study Model Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C165641.Outcome Measure Attribute Terminology" Name="Outcome Measure Attribute Terminology" DataType="text" nciodm:ExtCodeID="C165641">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the outcome measure entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Outcome Measure Description" nciodm:ExtCodeID="C165138">
                    <nciodm:CDISCDefinition>A full description of the outcome measure.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Outcome Measure Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcome Measure Time Frame" nciodm:ExtCodeID="C165859">
                    <nciodm:CDISCDefinition>The period of time over which the study outcome measure is assessed.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Outcome Measure Time Frame</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcome Measure Title" nciodm:ExtCodeID="C165860">
                    <nciodm:CDISCDefinition>The descriptive name of the outcome measure.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Outcome Measure Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcome Measure Type" nciodm:ExtCodeID="C165861">
                    <nciodm:CDISCDefinition>A characterization or classification of the specific key measurement(s) or observation(s) used to measure the effect of experimental variables on the participants in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Outcome Measure Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Outcome Measure Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Outcome Measure Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Outcome Measure Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C170442.Outcome Measure Type Value Set Terminology" Name="Outcome Measure Type Value Set Terminology" DataType="text" nciodm:ExtCodeID="C170442">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the type of outcome measure for the study.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Exploratory Outcome Measure" nciodm:ExtCodeID="C98724">
                    <nciodm:CDISCSynonym>Exploratory Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the exploratory endpoint(s) associated with exploratory study objective(s) and/or any other measures, excluding post-hoc measures, that are a focus of the study. (After clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Exploratory Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Outcome Measure" nciodm:ExtCodeID="C98772">
                    <nciodm:CDISCSynonym>Primary Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The outcome measure(s) of greatest importance specified in the protocol, usually the one(s) used in the power calculation, to evaluate the primary endpoint(s) associated with the primary study objective(s). (After Clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Outcome Measure" nciodm:ExtCodeID="C98781">
                    <nciodm:CDISCSynonym>Secondary Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the secondary endpoint(s) associated with secondary study objective(s) and/or used to evaluate any measure(s) ancillary to the primary or secondary endpoint(s). (After Clinicaltrials.gov).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Outcome Measure Type Value Set Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Outcome Measure Type Value Set Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Outcome Measure Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C165642.Oversight Entity Value Set" Name="Oversight Entity Value Set" DataType="text" nciodm:ExtCodeID="C165642">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the type of oversight entity for the study.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Data Monitoring Committee" nciodm:ExtCodeID="C142489">
                    <nciodm:CDISCSynonym>Data and Safety Monitoring Board</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Data and Safety Monitoring Committee DSMB</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Data Monitoring and Oversight Committee</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>DMC</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>DMOC</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>DSMC</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>IDMC</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Independent Data Monitoring Committee</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A group of independent experts who are appointed to monitor the safety and scientific integrity of a research intervention, protect the confidentiality of participant data, and to make recommendations to the sponsor regarding the stopping of the trial for safety, efficacy, or for futility. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Monitoring Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Independent Ethics Committee" nciodm:ExtCodeID="C142579">
                    <nciodm:CDISCSynonym>IEC</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An independent body (a review board or a committee, institutional, regional, national, or supranational), constituted of medical professionals and non-medical members, whose responsibility it is to ensure the protection of the rights, safety and well-being of human subjects involved in a study and to provide public assurance of that protection, by, among other things, reviewing and approving/providing favorable opinion on, the study protocol, the suitability of the investigator(s), facilities, and the methods and material to be used in obtaining and documenting informed consent of the study subjects. The legal status, composition, function, operations and regulatory requirements pertaining to Independent Ethics Committees may differ among countries, but should allow the Independent Ethics Committee to act in agreement with GCP as described in the ICH E6 guideline. (ICH E6 R2)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Independent Ethics Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Independent Safety Monitor" nciodm:ExtCodeID="C165865">
                    <nciodm:CDISCSynonym>ISM</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An independent physician or health-care professional who evaluates individual and cumulative participant data to make recommendations regarding the safe continuation of the study. (NIH)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Independent Safety Monitor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Institutional Review Board" nciodm:ExtCodeID="C16741">
                    <nciodm:CDISCSynonym>IRB</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An independent body constituted of medical, scientific, and non-scientific members, whose responsibility is to ensure the protection of the rights, safety and well-being of human subjects involved in a study by, among other things, reviewing, approving, and providing continuing review of study protocol and amendments and of the methods and material to be used in obtaining and documenting informed consent of the study subjects. (ICH E6 R2)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Institutional Review Board</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Observational Study Monitoring Committee" nciodm:ExtCodeID="C165866">
                    <nciodm:CDISCSynonym>Observational Study Monitoring Board</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>OSMB</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>OSMC</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A group of independent experts who are appointed to monitor the safety and scientific integrity of an observational study, including protecting the confidentiality of participant data and to make recommendations regarding the stopping of the study for safety or for futility. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study Monitoring Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Safety Monitoring Committee" nciodm:ExtCodeID="C165867">
                    <nciodm:CDISCSynonym>Safety Assessment Committee</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Safety Monitoring Board</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>SMC</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Group of individuals with pertinent expertise that reviews, on a regular basis, accumulating safety data from an ongoing clinical study. This independent committee monitors the safety of participants during the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Safety Monitoring Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Oversight Entity Value Set</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Oversight Entity Value Set</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Oversight Entity Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C147068.Participant Allocation Value Set" Name="Participant Allocation Value Set" DataType="text" nciodm:ExtCodeID="C147068">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist for the method of assigning participants, or subjects, to groups or categories within a clinical study.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Nonrandomized" nciodm:ExtCodeID="C93043">
                    <nciodm:CDISCDefinition>Participants are expressly assigned to intervention groups through a non-random method. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Nonrandomized Clinical Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Not Applicable" nciodm:ExtCodeID="C48660">
                    <nciodm:CDISCSynonym>NA</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Not Applicable</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Determination of a value is not relevant in the current context. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Not Applicable</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Randomized" nciodm:ExtCodeID="C25196">
                    <nciodm:CDISCSynonym>Trial is Randomized</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Participant Allocation Value Set</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Participant Allocation Value Set</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Subject Allocation Response Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C132308.Physical Address Attribute Terminology" Name="Physical Address Attribute Terminology" DataType="text" nciodm:ExtCodeID="C132308">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the physical address entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="City" nciodm:ExtCodeID="C25160">
                    <nciodm:CDISCDefinition>A relatively large and/or densely populated area of human habitation with administrative or legal status that may be specified as a component of a postal address.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>City</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Country" nciodm:ExtCodeID="C25464">
                    <nciodm:CDISCDefinition>A sovereign nation occupying a distinct territory and ruled by an autonomous government.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Country</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Geographic Locality" nciodm:ExtCodeID="C87189">
                    <nciodm:CDISCDefinition>A distinct geographic area in the immediate vicinity of a particular place, such as a city, neighborhood or district.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Locality</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Geographic Region" nciodm:ExtCodeID="C16632">
                    <nciodm:CDISCDefinition>Any demarcated area of the Earth; may be determined by both natural and human boundaries, such as a state or province.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Geographic Area</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Postal Code" nciodm:ExtCodeID="C25621">
                    <nciodm:CDISCDefinition>An alphanumeric code assigned to a mail delivery area.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Postal Code</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Province" nciodm:ExtCodeID="C25632">
                    <nciodm:CDISCDefinition>A sub-division of a country created by the central government for administrative purposes. Provinces are usually, but not always, less autonomous than states, and must obey the laws of the central government.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Province</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="State" nciodm:ExtCodeID="C87194">
                    <nciodm:CDISCDefinition>A sub-division of a country that forms part of a federal union. States are usually, but not always, more autonomous than provinces and may have different laws from the central government.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>State</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Street Address" nciodm:ExtCodeID="C25690">
                    <nciodm:CDISCDefinition>The street name and building number where an entity is located.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Street Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Physical Address Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Physical Address Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Physical Address Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C181167.Protocol Amendment Attribute Terminology" Name="Protocol Amendment Attribute Terminology" DataType="text" nciodm:ExtCodeID="C181167">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the protocol amendment.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Brief Rationale for Protocol Change" nciodm:ExtCodeID="C181233">
                    <nciodm:CDISCSynonym>Brief Rationale for Protocol Modification</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Brief Rationale for Protocol Revision</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A concise explanation justifying an individual change in the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Brief Rationale for Protocol Change</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Overall Rationale for Protocol Amendment" nciodm:ExtCodeID="C181234">
                    <nciodm:CDISCSynonym>Overall Justification for Amendment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A summarized explanation justifying a protocol amendment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Overall Rationale for Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol Version Approval by Sponsor Date" nciodm:ExtCodeID="C132352">
                    <nciodm:CDISCSynonym>Protocol Amendment Approval by Sponsor Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Protocol Version Approval Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The date on which a version of the protocol was finalized or approved by the sponsor.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Approval by Sponsor Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol Version Number" nciodm:ExtCodeID="C181232">
                    <nciodm:CDISCSynonym>Study Protocol Amendment Number</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A string of numerals that uniquely identifies a specific version of a study protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Protocol Amendment Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Protocol Amendment Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Amendment Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C154681.Protocol Contact Role Value Set" Name="Protocol Contact Role Value Set" DataType="text" nciodm:ExtCodeID="C154681">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the role that the individual or entity plays with respect to being a contact within a study protocol.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Biostatistician" nciodm:ExtCodeID="C154709">
                    <nciodm:CDISCDefinition>A person who is responsible for the statistical aspects of the clinical or pre-clinical study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biostatistician</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Informaticist" nciodm:ExtCodeID="C154708">
                    <nciodm:CDISCSynonym>Clinical Informatician</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An individual that designs, implements, evaluates and/or analyzes information technology in a healthcare or research setting. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Informaticist</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Research Coordinator" nciodm:ExtCodeID="C51811">
                    <nciodm:CDISCSynonym>CRC</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A person to whom a clinical investigator delegates routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject's clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Coordinator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Contact for Public Queries" nciodm:ExtCodeID="C127526">
                    <nciodm:CDISCDefinition>The study contact person who is responsible for questions from the public.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Public Queries Study Contact</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Coordinating Investigator" nciodm:ExtCodeID="C51818">
                    <nciodm:CDISCDefinition>An investigator assigned the responsibility for the coordination of investigators at different centers participating in a multi-center trial. While a single-center study would not include a coordinating investigator, the investigator at the site would fulfill the same responsibilities as a principal investigator. (after ICH E6)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Coordinating Investigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Manager" nciodm:ExtCodeID="C51820">
                    <nciodm:CDISCDefinition>An individual who is responsible for the development and implementation of architectures, policies and procedures for the effective management of data across its business lifecycle.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Manager</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigator" nciodm:ExtCodeID="C25936">
                    <nciodm:CDISCDefinition>A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principal investigator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Investigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Legal Representative for the Study" nciodm:ExtCodeID="C127532">
                    <nciodm:CDISCDefinition>An individual with expertise in the law who provides legal counsel and representation for a study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Legal Representative for the Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Medical Monitor" nciodm:ExtCodeID="C51836">
                    <nciodm:CDISCDefinition>A sponsor representative who has medical authority for the evaluation of the safety aspects of a clinical trial. (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Medical Monitor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="National Coordinating Investigator" nciodm:ExtCodeID="C154706">
                    <nciodm:CDISCDefinition>In the case of a multinational study, a person who has the responsibilities of the sponsor of the study in his/her country and will be responsible for the coordination of the principal investigators at different sites within that member state. (EMA)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>National Coordinating Investigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Sponsor" nciodm:ExtCodeID="C70794">
                    <nciodm:CDISCDefinition>The individual, organization, group or other legal person taking responsibility for securing the arrangements to initiate and/or manage a study (including arrangements to ensure that the study design meets appropriate standards and to ensure appropriate conduct and reporting). In commercial trials, the primary sponsor is normally the main applicant for regulatory authorization to begin the study. It may or may not be the main funder. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Principal Investigator" nciodm:ExtCodeID="C19924">
                    <nciodm:CDISCDefinition>A person who has the primary responsibility for the conduct of a clinical study and study-related personnel at a study site. While a single-center study would not include a coordinating investigator, the investigator at the site would fulfill the same responsibilities as a principal investigator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Principal Investigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Sponsor" nciodm:ExtCodeID="C70795">
                    <nciodm:CDISCDefinition>Additional individuals, organizations or other legal persons, if any, that have agreed with the primary sponsor to take on responsibilities of sponsorship. A secondary sponsor may have agreed to take on all the responsibilities of sponsorship jointly with the primary sponsor; or to form a group with the primary sponsor in which the responsibilities of sponsorship are allocated among the members of the group; or to act as the sponsor's legal representative in relation to some or all of the study sites; or to take responsibility for the accuracy of study registration information submitted.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor" nciodm:ExtCodeID="C70793">
                    <nciodm:CDISCSynonym>Clinical Study Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An entity that is responsible for the initiation, management, and/or financing of a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Chair" nciodm:ExtCodeID="C51878">
                    <nciodm:CDISCSynonym>Study Director</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A person who has overall responsibility for the technical conduct of a study, as well as for the interpretation, analysis, documentation and reporting of results, and represents the single point of study control. (FDA)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Chair</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Subinvestigator" nciodm:ExtCodeID="C54622">
                    <nciodm:CDISCDefinition>Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Subinvestigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Technical Lead" nciodm:ExtCodeID="C154707">
                    <nciodm:CDISCDefinition>An individual who is responsible for the delivery of technical aspects of a project. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Technical Lead</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Protocol Contact Role Value Set</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Protocol Contact Role Value Set</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Protocol Contact Role Response Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C132310.Protocol Entity Terminology" Name="Protocol Entity Terminology" DataType="text" nciodm:ExtCodeID="C132310">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the entities within a protocol.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Biological Sample" nciodm:ExtCodeID="C70699">
                    <nciodm:CDISCSynonym>Biological Sample</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Biological Specimen</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Biospecimen</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Sample</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any material collected from a biological entity for testing, diagnostic, propagation, treatment, or research purposes.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Study" nciodm:ExtCodeID="C15206">
                    <nciodm:CDISCDefinition>A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. [ClinicalTrials.gov] See also clinical trial. (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Trial" nciodm:ExtCodeID="C71104">
                    <nciodm:CDISCDefinition>1) A research investigation involving human subjects that is designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device) or new ways of using a known drug, treatment, or device). 2) A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.(1. modified from ICH E6 Glossary, Directive 2001/20/EC. 2. NIH revised definition 2015) (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Endpoint" nciodm:ExtCodeID="C25212">
                    <nciodm:CDISCDefinition>A defined variable intended to reflect an outcome measure of interest that is statistically analyzed to address a particular research question. NOTE: A precise definition of an endpoint typically specifies the type of assessments made, the timing of those assessments, the assessment tools used, and possibly other details, as applicable, such as how multiple assessments within an individual are to be combined. [After BEST Resource] (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>End Point</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Informed Consent" nciodm:ExtCodeID="C16735">
                    <nciodm:CDISCDefinition>Consent given by a subject, or in the case of an individual that can only give assent, by a parent or legal guardian, for the participation in a clinical study only after having achieved an understanding of both the relevant medical facts and the relevant risks involved.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Informed Consent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Ingredient" nciodm:ExtCodeID="C51981">
                    <nciodm:CDISCDefinition>Any component that constitutes a part of a compound or mixture.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Ingredient</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention" nciodm:ExtCodeID="C25218">
                    <nciodm:CDISCDefinition>The drug, device, therapy, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study. [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224] (CDISC-Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention or Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcome Measure" nciodm:ExtCodeID="C93407">
                    <nciodm:CDISCDefinition>Specific key measurement(s) or observation(s) used to measure the effect of experimental variables on the participants in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. (BRIDG)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Outcome Measurement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcome" nciodm:ExtCodeID="C20200">
                    <nciodm:CDISCDefinition>Events or experiences that clinicians or investigators examining the impact of an intervention or exposure measure because they believe such events or experiences may be influenced by the research intervention or exposure. Outcome is a general term in that it does not necessarily relate to a planned objective of the study. (FDA)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Outcome</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Physical Address" nciodm:ExtCodeID="C25407">
                    <nciodm:CDISCDefinition>A standardized representation of the location of a person, business, building, or organization. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Amendment" nciodm:ExtCodeID="C132347">
                    <nciodm:CDISCDefinition>A written description of a change(s) to, or formal clarification of, a protocol. (ICH E6)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Statement" nciodm:ExtCodeID="C181183">
                    <nciodm:CDISCDefinition>A written message providing an official assurance, account, or assertion within the study protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Quality Assurance" nciodm:ExtCodeID="C15381">
                    <nciodm:CDISCSynonym>QA</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>All those planned and systematic actions that are established to ensure that the study is performed and the data are generated, documented (recorded), and reported in compliance with good clinical practice (GCP) and the applicable regulatory requirement(s). (ICH)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Quality Assurance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Quality Control" nciodm:ExtCodeID="C15311">
                    <nciodm:CDISCSynonym>QC</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The operational techniques and activities undertaken within the quality assurance system to verify that the requirements for quality of the study related activities have been fulfilled. (ICH)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Quality Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reference" nciodm:ExtCodeID="C184397">
                    <nciodm:CDISCSynonym>Reference List</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The curated list of sources that are cited within the reference section of the document.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Reference List</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Arm" nciodm:ExtCodeID="C174447">
                    <nciodm:CDISCSynonym>Arm</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A planned pathway assigned to the subject as they progress through the study, usually referred to by a name that reflects one or more treatments, exposures, and/or controls included in the path.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Contact Information" nciodm:ExtCodeID="C154705">
                    <nciodm:CDISCDefinition>Information regarding the means of contacting a person or group that performs a function within a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Contact Information</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Design" nciodm:ExtCodeID="C15320">
                    <nciodm:CDISCDefinition>A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and informing the statistical approach.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Monitoring" nciodm:ExtCodeID="C142707">
                    <nciodm:CDISCDefinition>The act of overseeing the progress of a clinical study and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), good clinical practice (GCP), and regulatory requirement(s) where applicable. [after ICH E6 Glossary]</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Oversight Entity" nciodm:ExtCodeID="C93450">
                    <nciodm:CDISCDefinition>A group of individuals that approves, monitors and reviews biomedical research to protect the rights, safety and welfare of the study participants, by providing critical scientific, ethical, and/or regulatory oversight functions.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Oversight Authority</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Population" nciodm:ExtCodeID="C70833">
                    <nciodm:CDISCDefinition>A group of individuals taken from the general population who share a set of common characteristics, such as age, sex, or health condition, precisely defined in the study protocol. This is a population to which the study results could be reasonably generalized.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Population</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Administration" nciodm:ExtCodeID="C177924">
                    <nciodm:CDISCDefinition>The act of the dispensing, applying, or tendering a study product to the participant. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product" nciodm:ExtCodeID="C174271">
                    <nciodm:CDISCDefinition>The material artifact(s), such as the trial product, interventional product, study drug, device, or procedure and their comparator(s), that is the focus of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol" nciodm:ExtCodeID="C70817">
                    <nciodm:CDISCDefinition>The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study, intervention description, and method of data analysis.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Protocol Entity Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Protocol Entity Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C181168.Protocol Statement Attribute Terminology" Name="Protocol Statement Attribute Terminology" DataType="text" nciodm:ExtCodeID="C181168">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the protocol statement.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Biological Sample Use Statement" nciodm:ExtCodeID="C181244">
                    <nciodm:CDISCSynonym>Biological Specimen Use Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Biospecimen Use Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that describes the provisions for use of biological samples for the duration of the study and, as applicable, for future use.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biological Sample Use Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Conflict of Interest Statement" nciodm:ExtCodeID="C181240">
                    <nciodm:CDISCDefinition>A written message within the study protocol that describes how the study will manage actual or perceived conflicts of interest, including report to regulatory authorities and oversight entities.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Conflict of Interest Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Integrity Statement" nciodm:ExtCodeID="C181237">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts that the data are complete, consistent, accurate, trustworthy, and reliable throughout the life cycle of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Integrity Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Sharing Statement" nciodm:ExtCodeID="C184394">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts compliance with data sharing policies.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Sharing Compliance Policy Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Financial Disclosure Statement" nciodm:ExtCodeID="C181241">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts how any and all financial interests of the study stakeholders will be managed in relation to the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Financial Disclosure Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Confidentiality Statement" nciodm:ExtCodeID="C181236">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts a statement of non-disclosure, such that information contained within the protocol document may only be shared with authorized parties.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Confidentiality Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Regulatory Compliance Statement" nciodm:ExtCodeID="C181235">
                    <nciodm:CDISCSynonym>Regulatory Compliance Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts that the study will be conducted in compliance with Good Clinical Practice (GCP) guidelines, study protocol, and any other applicable regulatory requirements.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Regulatory Compliance Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Publication Policy Statement" nciodm:ExtCodeID="C184393">
                    <nciodm:CDISCDefinition>A written message within the study protocol that describes the policies pertaining to the publication of study results.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Publication Policy Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Statement of Ethical Conduct" nciodm:ExtCodeID="C181239">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts that the study will be conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and applicable regional regulations and guidelines.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Statement of Ethical Conduct</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Statement of Progress Reporting" nciodm:ExtCodeID="C181238">
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts timely communication of study progress and results to the study stakeholders as well as regulatory authorities and study registries.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Statement of Progress Reporting</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Investigator Conduct Statement" nciodm:ExtCodeID="C184392">
                    <nciodm:CDISCSynonym>Investigator Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Investigator Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts that a study investigator will be responsible for the performance and conduct of the study as described in the protocol, and in accordance with relevant laws, regulations, and guidelines.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Investigator Conduct Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Sponsor Conduct Statement" nciodm:ExtCodeID="C184391">
                    <nciodm:CDISCSynonym>Sponsor Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Sponsor Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts that the study sponsor will be responsible for overseeing all aspects of study conduct.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Sponsor Conduct Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Subject Data Confidentiality Statement" nciodm:ExtCodeID="C181243">
                    <nciodm:CDISCSynonym>Study Participant Data Confidentiality Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts compliance with applicable regulations and guidelines to preserve and maintain study data confidentiality.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Subject Data Confidentiality Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Subject Privacy Statement" nciodm:ExtCodeID="C181242">
                    <nciodm:CDISCSynonym>Study Participant Privacy Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message within the study protocol that asserts compliance with applicable regulations and guidelines regarding the protection of study subject, or participant, privacy.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Subject Privacy Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Protocol Statement Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Protocol Statement Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Statement Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C147069.Randomization Type Value Set" Name="Randomization Type Value Set" DataType="text" nciodm:ExtCodeID="C147069">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the types of randomization schemas associated with a randomized controlled trial.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Adaptive Randomization" nciodm:ExtCodeID="C147126">
                    <nciodm:CDISCDefinition>A type of randomization schema in which the group assignment probability of a participant is adjusted based on the group assignments of those participants already randomized in the trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Adaptive Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Block Randomization" nciodm:ExtCodeID="C147127">
                    <nciodm:CDISCSynonym>Constrained Randomization</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of adaptive randomization in which a pre-specified number of participants is assigned to a block containing the same pre-specified number of balanced group assignments in random order.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Block Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Minimization Randomization" nciodm:ExtCodeID="C147143">
                    <nciodm:CDISCSynonym>Covariate Adaptive Randomization</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of adaptive randomization in which the participant is assigned to the treatment group in an attempt to minimize imbalances in the number of participants for each stratification covariate across treatment groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Minimization Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Simple Randomization" nciodm:ExtCodeID="C147144">
                    <nciodm:CDISCSynonym>Unrestricted Randomization</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of randomization schema in which each participant has the same chance of being randomized into any one group as all other participants.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Simple Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stratified Randomization" nciodm:ExtCodeID="C147145">
                    <nciodm:CDISCDefinition>A type of block randomization in which participants are stratified into groups based on prognostic variables and then randomized into balanced treatment groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Stratified Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Unequal Randomization" nciodm:ExtCodeID="C142743">
                    <nciodm:CDISCDefinition>A type of randomization schema in which unequal numbers of participants are purposely assigned to multiple treatment groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Unequal Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Randomization Type Value Set</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Randomization Type Value Set</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Randomization Type Response Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C184333.Reference Attribute Terminology" Name="Reference Attribute Terminology" DataType="text" nciodm:ExtCodeID="C184333">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the reference.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Citation" nciodm:ExtCodeID="C41196">
                    <nciodm:CDISCDefinition>A reference to an authoritative source.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Citation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Reference Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Reference Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Reference Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C172329.Study Arm Attribute Terminology" Name="Study Arm Attribute Terminology" DataType="text" nciodm:ExtCodeID="C172329">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study arm entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Planned Number of Subjects Per Study Arm" nciodm:ExtCodeID="C172458">
                    <nciodm:CDISCDefinition>The total number of subjects intended to be included within each arm for the study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Number of Subjects Per Study Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Arm Description" nciodm:ExtCodeID="C93728">
                    <nciodm:CDISCSynonym>Arm Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The textual representation of the arm for the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Arm Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Arm Label" nciodm:ExtCodeID="C172456">
                    <nciodm:CDISCSynonym>Arm Label</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The given name of the arm for the study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Arm Label</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Arm Type" nciodm:ExtCodeID="C172457">
                    <nciodm:CDISCSynonym>Arm Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The identification of the kind of arm(s) for the study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Arm Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Arm Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Arm Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Arm Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C174222.Study Arm Type Value Set Terminology" Name="Study Arm Type Value Set Terminology" DataType="text" nciodm:ExtCodeID="C174222">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the identification of the kind of arm.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Active Comparator Arm" nciodm:ExtCodeID="C174267">
                    <nciodm:CDISCDefinition>An arm describing the active comparator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Active Comparator Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Control Arm" nciodm:ExtCodeID="C174226">
                    <nciodm:CDISCDefinition>An arm describing the intervention or treatment plan for a group of participants in the study receiving a control. The control may comprise a non-investigational product (active control) or regimen, placebo, or no treatment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Control Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Experimental Arm" nciodm:ExtCodeID="C174266">
                    <nciodm:CDISCSynonym>Investigational Arm</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An arm describing the intervention or treatment plan for a group of participants in the study receiving test product(s).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Investigational Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="No Intervention Arm" nciodm:ExtCodeID="C174270">
                    <nciodm:CDISCDefinition>A study arm without an intervention or treatment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>No Intervention Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Placebo Comparator Arm" nciodm:ExtCodeID="C174268">
                    <nciodm:CDISCSynonym>Placebo Control Arm</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An arm describing the placebo comparator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Placebo Control Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sham Comparator Arm" nciodm:ExtCodeID="C174269">
                    <nciodm:CDISCSynonym>Sham Intervention Arm</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An arm describing the sham comparator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Sham Comparator Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Treatment Arm" nciodm:ExtCodeID="C15538">
                    <nciodm:CDISCDefinition>An arm describing the intervention or treatment plan for a group of participants in the study. Treatment may consist of either experimental or control products under investigation.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Treatment Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Arm Type Value Set Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Arm Type Value Set Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Arm Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C154682.Study Contact Information Attribute Terminology" Name="Study Contact Information Attribute Terminology" DataType="text" nciodm:ExtCodeID="C154682">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study contact information entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Academic Degree" nciodm:ExtCodeID="C25354">
                    <nciodm:CDISCDefinition>An academic rank conferred by a college, university, or other postsecondary education institution as official recognition for the successful completion of a program of studies.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Academic Degree</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="E-mail Address" nciodm:ExtCodeID="C42775">
                    <nciodm:CDISCSynonym>Email Address</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A text string identifier for a location to which electronic mail can be delivered. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>E-mail Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Fax Number" nciodm:ExtCodeID="C42879">
                    <nciodm:CDISCSynonym>Facsimile Number</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A telephone number that is used for identifying a specific fax machine in a telephone network.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Fax Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Organizational Affiliation" nciodm:ExtCodeID="C154704">
                    <nciodm:CDISCDefinition>The name of the organization or entity that the person or group has an established relationship with.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Organizational Affiliation Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Person Name" nciodm:ExtCodeID="C25191">
                    <nciodm:CDISCSynonym>Individual's Name</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Name</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A word or group of words indicating the identity of a person usually consisting of a first (personal) name and a last (family) name with an optional middle name. In some cultural traditions the family name comes first.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Person Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Physical Address" nciodm:ExtCodeID="C25407">
                    <nciodm:CDISCDefinition>A standardized representation of the location of a person, business, building, or organization. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Role" nciodm:ExtCodeID="C48835">
                    <nciodm:CDISCDefinition>The usual or expected function of something; the part something plays in an action or event. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Role</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Telephone Number" nciodm:ExtCodeID="C40978">
                    <nciodm:CDISCSynonym>Phone Number</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A sequence of decimal digits (0-9) that is used for identifying a specific telephone line or other device in a telephone network.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Telephone Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Contact Information Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Contact Information Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Study Contact Information Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C147066.Study Design Attribute Terminology" Name="Study Design Attribute Terminology" DataType="text" nciodm:ExtCodeID="C147066">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study design entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Blinding" nciodm:ExtCodeID="C49068">
                    <nciodm:CDISCSynonym>Masking</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A process to limit bias by preventing subjects and/ or study personnel from identifying which treatments or procedures are administered, or from learning the results of tests and measures undertaken as part of a clinical investigation. (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Blinded</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Interventional Study Design" nciodm:ExtCodeID="C98746">
                    <nciodm:CDISCSynonym>Intervention Model</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Observational Study Design" nciodm:ExtCodeID="C147138">
                    <nciodm:CDISCSynonym>Observation Model</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The general design of the strategy for identifying and following up with participants during observational studies. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Overall Study Design" nciodm:ExtCodeID="C147139">
                    <nciodm:CDISCSynonym>Overall Design</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Design Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Design Overview</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Summary of Study Design</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Summary description of the overall study plan and design, should include treatments studied, population studied, level and method of blinding/unmasking, kind of controls, method of assignment to treatment, sequence and duration of study periods, any safety, data monitoring or special steering or evaluation committees, and interim analyses. (ICH E3)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Design Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participant Allocation" nciodm:ExtCodeID="C52580">
                    <nciodm:CDISCSynonym>Subject Allocation</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The process of assigning participants to particular treatment groups or cohorts in a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Allocation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Planned Number of Arms" nciodm:ExtCodeID="C98771">
                    <nciodm:CDISCSynonym>Planned Number of Arms</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned number of intervention groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Number of Arms</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Planned Number of Cohorts" nciodm:ExtCodeID="C147137">
                    <nciodm:CDISCDefinition>The planned number of study groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Number of Cohorts</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Planned Number of Participants" nciodm:ExtCodeID="C49692">
                    <nciodm:CDISCSynonym>Anticipated Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Planned Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Planned Number of Subjects</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Target Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned number of subjects to be entered in a clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Subject Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Randomization Type" nciodm:ExtCodeID="C147140">
                    <nciodm:CDISCDefinition>A characterization or classification of the process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Randomization Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stratification Factor" nciodm:ExtCodeID="C16153">
                    <nciodm:CDISCSynonym>Stratification Factor</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Selected factors that are used during randomization to ensure there is balance of these factors across all subjects within each arm of a study. The subject level values of these factors may be used as fixed effects in statistical models and for sensitivity analyses.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Stratification Factors</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stratification" nciodm:ExtCodeID="C25689">
                    <nciodm:CDISCDefinition>Grouping defined by important prognostic factors measured at baseline. (ICH E9)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Stratification</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Design Rationale" nciodm:ExtCodeID="C142705">
                    <nciodm:CDISCDefinition>Reason(s) for choosing the study design. This may include reasons for the choice of control or comparator, as well as the scientific rationale for the study design.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Design Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Hypothesis" nciodm:ExtCodeID="C142668">
                    <nciodm:CDISCDefinition>A supposition or proposal made to explain certain observations or facts, which requires further investigation or exploration within a clinical study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Research Hypothesis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Primary Purpose" nciodm:ExtCodeID="C147141">
                    <nciodm:CDISCDefinition>The principal reason or intention for the execution of an interventional or non-interventional clinical study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Primary Purpose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Secondary Purpose" nciodm:ExtCodeID="C147142">
                    <nciodm:CDISCDefinition>The ancillary reason or intention for the execution of an interventional or non-interventional clinical study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Secondary Purpose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Blinding Schema" nciodm:ExtCodeID="C49658">
                    <nciodm:CDISCSynonym>Trial Blinding Schema</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The type of experimental design used to describe the level of awareness of the clinical trial subjects and/or investigators of the intervention(s) that they are receiving and/or administering.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Blinding Schema</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Design Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Design Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Study Design Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C163026.Study Monitoring Attribute Terminology" Name="Study Monitoring Attribute Terminology" DataType="text" nciodm:ExtCodeID="C163026">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study monitoring entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Clinical Monitoring Plan" nciodm:ExtCodeID="C115753">
                    <nciodm:CDISCDefinition>A description of the strategy, methods, responsibilities, and requirements for monitoring the study. (ICH E6(R2))</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Monitoring Plan</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data and Safety Monitoring Plan" nciodm:ExtCodeID="C163406">
                    <nciodm:CDISCSynonym>Data Safety Monitoring Plan</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>DSMP</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Safety Data Monitoring Plan</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written plan that prospectively identifies and documents monitoring activities intended to protect the safety of the participants, the validity of the data and the integrity of the research study. The DSMP may also identify when to terminate a participant's participation (i.e. individual stopping rules) and/or the appropriate termination of a study (i.e. study stopping rules). (Mayo Clinic)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data and Safety Monitoring Plan</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Monitoring" nciodm:ExtCodeID="C142488">
                    <nciodm:CDISCDefinition>Review of study data for completeness, consistency, and accuracy for the duration of the study lifecycle.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="GCP Adherence Statement" nciodm:ExtCodeID="C163407">
                    <nciodm:CDISCSynonym>Good Clinical Practice Adherence Statement</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A written message that asserts, affirms, or declares that the study is conducted in accordance with Good Clinical Practice (GCP).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>GCP Adherence Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Risk Monitoring" nciodm:ExtCodeID="C142674">
                    <nciodm:CDISCDefinition>A systematic, prioritized approach that involves identifying, assessing, monitoring and mitigating the risks that could affect the quality of the study or safety of the study participants.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Risk Based Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Safety Data Monitoring" nciodm:ExtCodeID="C163408">
                    <nciodm:CDISCDefinition>Review of cumulative safety data to identify possible safety concerns.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Safety Data Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Safety Monitoring" nciodm:ExtCodeID="C163409">
                    <nciodm:CDISCDefinition>Review of safety data to ensure safety of the individuals who are participating in the study, or to identify potential safety concerns for the duration of the study lifecycle.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Safety Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Audit Statement" nciodm:ExtCodeID="C184395">
                    <nciodm:CDISCDefinition>A written message within the study protocol that describes the auditing activities that are to occur within a study and the intent to address findings from an audit report.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Audit Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Audit" nciodm:ExtCodeID="C184396">
                    <nciodm:CDISCDefinition>A systematic and independent examination of study-related activities and documents to determine whether the evaluated trial-related activities were conducted and the data were recorded, analyzed, and accurately reported according to the protocol, sponsor's standard operating procedures (SOPs), good clinical practice (GCP), and the applicable regulatory requirement(s). (ICH E6 Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Audit</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Monitoring Statement" nciodm:ExtCodeID="C163410">
                    <nciodm:CDISCDefinition>A written message that asserts, affirms, or declares that the study will be monitored in adherence to a clinical monitoring plan and in accordance with Good Clinical Practice (GCP).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Monitoring Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Suicidal Risk Monitoring" nciodm:ExtCodeID="C163411">
                    <nciodm:CDISCDefinition>A systematic approach to identify and assess the risks of participant suicidal ideation and/or suicide.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Suicidal Risk Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Monitoring" nciodm:ExtCodeID="C15789">
                    <nciodm:CDISCDefinition>The act of overseeing the progress of a clinical trial and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), good clinical practice (GCP), and the applicable regulatory requirement(s). [ICH E6 Glossary]</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trials, Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Monitoring Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Monitoring Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Monitoring Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C165640.Study Oversight Entity Attribute Terminology" Name="Study Oversight Entity Attribute Terminology" DataType="text" nciodm:ExtCodeID="C165640">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study oversight entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Study Oversight Entity Approval Date" nciodm:ExtCodeID="C165862">
                    <nciodm:CDISCDefinition>The date on which the study oversight entity grants approval.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Oversight Entity Approval Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Oversight Entity Approval Status" nciodm:ExtCodeID="C165863">
                    <nciodm:CDISCDefinition>The state of the study oversight entity approval process.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Oversight Entity Approval Status</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Oversight Entity Type" nciodm:ExtCodeID="C165864">
                    <nciodm:CDISCDefinition>A characterization or classification of the group of individuals that approves, monitors and reviews biomedical research to protect the rights, safety and welfare of the study participants, by providing critical scientific, ethical, and/or regulatory oversight functions.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Oversight Entity Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Oversight Entity Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Oversight Entity Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Oversight Entity Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C160921.Study Population Attribute Terminology" Name="Study Population Attribute Terminology" DataType="text" nciodm:ExtCodeID="C160921">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study population entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Comorbid Condition" nciodm:ExtCodeID="C161320">
                    <nciodm:CDISCDefinition>Medical or health condition that is concomitant or concurrent with the primary condition or disease under study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Comorbid Condition</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Condition or Disease under Study" nciodm:ExtCodeID="C161319">
                    <nciodm:CDISCDefinition>Primary disease(s) or condition(s) being studied in the trial, or the focus of the study. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Condition or Disease under Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Control Group" nciodm:ExtCodeID="C28143">
                    <nciodm:CDISCDefinition>A study population that is defined for the purpose of comparison to the treatment group in a controlled trial. In an epidemiological study, a study population that does not have the outcome of interest.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Control Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Demographic Group" nciodm:ExtCodeID="C161324">
                    <nciodm:CDISCDefinition>A descriptive characterization of the study population (e.g., age, sex, race, education, etc.).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Demographic Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Experimental Group" nciodm:ExtCodeID="C161323">
                    <nciodm:CDISCDefinition>A study population that receives the intervention that is the focus of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Experimental Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Females of Childbearing Potential" nciodm:ExtCodeID="C161316">
                    <nciodm:CDISCSynonym>FOCBP</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>WOCBP</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Women of Childbearing Potential</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Female study subjects or patients who have the potential to become pregnant, i.e., those who have experienced menarche and who have not undergone surgical sterilization and are not postmenopausal.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Female of Childbearing Potential</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="General Health Status" nciodm:ExtCodeID="C16669">
                    <nciodm:CDISCDefinition>The state of a subject's mental or physical condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Health Status</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Healthy Volunteer" nciodm:ExtCodeID="C49651">
                    <nciodm:CDISCSynonym>Healthy Subject</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An individual who is or becomes a participant in a research study and has no significant health-related issues. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Healthy Subject</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Justification of Special Population" nciodm:ExtCodeID="C161318">
                    <nciodm:CDISCDefinition>An explanation with defensible proof as to the reason why a special population of subjects is included in the clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Justification of Special Population</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Population Rationale" nciodm:ExtCodeID="C161317">
                    <nciodm:CDISCDefinition>An explanation as to the logical reasons for why a specific population of subjects is being considered for inclusion in a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Population Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reference Group" nciodm:ExtCodeID="C161321">
                    <nciodm:CDISCSynonym>Reference Group for Study Sample Population</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The study population that is defined for the purpose of comparison to the population under investigation.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Reference Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Target Study Population" nciodm:ExtCodeID="C142728">
                    <nciodm:CDISCSynonym>Target Population</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The population within the general population for which the study results can be generalized.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Target Study Population</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Treatment Group" nciodm:ExtCodeID="C161322">
                    <nciodm:CDISCDefinition>A study population that receives an intervention(s) within a trial. This could include the investigational product(s) or a comparator (e.g., placebo or an approved intervention).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Treatment Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Vulnerable Population" nciodm:ExtCodeID="C142747">
                    <nciodm:CDISCDefinition>Individuals whose willingness to volunteer in a clinical trial may be unduly influenced by the expectation, whether justified or not, of benefits associated with participation, or of a retaliatory response from senior members of a hierarchy in case of refusal to participate. Examples include subordinate members of a group with a hierarchical structure, patients with incurable diseases, persons in nursing homes, unemployed or impoverished persons, patients in emergency situations, ethnic minority groups, homeless persons, nomads, refugees, minors, and those incapable of giving consent. (ICH)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Vulnerable Subjects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Population Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Population Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Population Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C177904.Study Product Administration Attribute" Name="Study Product Administration Attribute" DataType="text" nciodm:ExtCodeID="C177904">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study product administration.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Dosage Form" nciodm:ExtCodeID="C42636">
                    <nciodm:CDISCSynonym>Dose Form</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The physical form in which active and/or inert ingredient(s) are presented.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmaceutical Dosage Form</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dosage Regimen" nciodm:ExtCodeID="C142516">
                    <nciodm:CDISCDefinition>The schedule of doses of a therapeutic agent per unit of time, including: the time between doses (e.g., every 6 hours) or the time when the dose(s) are to be given (e.g., at 8 a.m. and 4 p.m. daily), and the amount of a medicine (e.g., number of capsules) to be given at each specific time. (Segen's Medical Dictionary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dosage Regimen</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dose Frequency" nciodm:ExtCodeID="C89081">
                    <nciodm:CDISCSynonym>Dosing Frequency</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The number of doses administered per a specific interval.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose Frequency</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dose" nciodm:ExtCodeID="C25488">
                    <nciodm:CDISCSynonym>Dose Level</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Dose per Administration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The amount of study drug (or placebo) administered to a patient or test subject to be taken at one time or at stated intervals.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Justification for Dosage" nciodm:ExtCodeID="C177925">
                    <nciodm:CDISCDefinition>The rationale or explanation for the planned dose(s).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Justification for Planned Dosage</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Justification of Administration" nciodm:ExtCodeID="C177926">
                    <nciodm:CDISCDefinition>The rationale or explanation for the planned mode of delivery.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Justification of Planned Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Route of Administration" nciodm:ExtCodeID="C38114">
                    <nciodm:CDISCSynonym>Route of Administration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The pathway by which a substance is administered in order to reach the site of action in the body.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Route of Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Product Administration Attribute</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Product Administration Attribute</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Product Administration Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C174220.Study Product Attribute Terminology" Name="Study Product Attribute Terminology" DataType="text" nciodm:ExtCodeID="C174220">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study product.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Study Product Accountability" nciodm:ExtCodeID="C176267">
                    <nciodm:CDISCDefinition>The act or process for documenting the storage, inventory tracking, and disposition of the study product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Accountability</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Acquisition" nciodm:ExtCodeID="C176266">
                    <nciodm:CDISCDefinition>The act or process by which the study product is obtained by the study site or investigator.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Acquisition</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Appearance" nciodm:ExtCodeID="C176269">
                    <nciodm:CDISCDefinition>The outward or visible aspect of the study product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Appearance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Formulation" nciodm:ExtCodeID="C176268">
                    <nciodm:CDISCDefinition>The composition of the study product, which may include active and inactive ingredients, dose, and dosage form.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Formulation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Labeling" nciodm:ExtCodeID="C176271">
                    <nciodm:CDISCDefinition>The written, printed, or graphic matter on, or accompanying, the study product or its packaging.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Labeling</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Manufacturer" nciodm:ExtCodeID="C176275">
                    <nciodm:CDISCDefinition>The enterprise or entity that produces the study product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Manufacturer</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Packaging" nciodm:ExtCodeID="C176270">
                    <nciodm:CDISCDefinition>The material type and configuration used to contain the study product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Packaging</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Pharmacologic Class" nciodm:ExtCodeID="C98768">
                    <nciodm:CDISCSynonym>Pharmacologic Class</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The pharmacological class of the investigational product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacological Class of Investigational Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Preparation" nciodm:ExtCodeID="C176274">
                    <nciodm:CDISCDefinition>Instructions for the act of making ready the study product for use or administration.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Preparation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Stability" nciodm:ExtCodeID="C176273">
                    <nciodm:CDISCDefinition>The parameters under which the study product retains the same properties and characteristics that it possessed at the time of its manufacture for its intended use or administration. (After Anissa W. Wong, Aruna Datla.13-Assay and Stability Testing, Editor(s): Satinder Ahuja, Michael W. Dong, Separation Science and Technology, Academic Press, Volume 6, 2005, Pages 335-358)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Stability</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Storage" nciodm:ExtCodeID="C176272">
                    <nciodm:CDISCDefinition>The physical or environmental conditions under which the study product is maintained.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Storage</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Therapeutic Class" nciodm:ExtCodeID="C177927">
                    <nciodm:CDISCSynonym>Study Product Therapeutic Category</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The classification of a study product based on the disease, disorder, or condition it is intended to treat.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Therapeutic Class</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Product Type" nciodm:ExtCodeID="C174265">
                    <nciodm:CDISCDefinition>The characterization or classification of the material artifact(s) that is the focus of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Product Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Product Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Product Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Product Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C174221.Study Product Type Value Set Terminology" Name="Study Product Type Value Set Terminology" DataType="text" nciodm:ExtCodeID="C174221">
                <Description>
                    <TranslatedText xml:lang="en">The terminology relevant to the identification of the kind of study product.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Active Comparator" nciodm:ExtCodeID="C68609">
                    <nciodm:CDISCSynonym>Active Control</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of control, which has a demonstrated effect, administered as a comparator to subjects in a clinical trial. [From ICH E10]</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Active Comparator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Control Product" nciodm:ExtCodeID="C142703">
                    <nciodm:CDISCDefinition>A comparator product against which the study treatment is evaluated [e.g., concurrent (placebo, no treatment, dose-response, active), and external (historical, published literature)]. [After ICH E10]</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigational Product" nciodm:ExtCodeID="C142587">
                    <nciodm:CDISCSynonym>Experimental Product</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A material (such as a drug, biologic, or device) produced by or resulting from a process, which is being tested in a study. This may also include a product with a marketing authorization when used or assembled (formulated or packaged) in a way different from the approved form, or when used for an unapproved indication, or when used to gain further information about an approved use. [After ICH]</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Investigational Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Placebo Comparator" nciodm:ExtCodeID="C49648">
                    <nciodm:CDISCSynonym>Placebo</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Placebo Control</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An inactive, identical-appearing drug or treatment that does not contain the test product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Placebo Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sham Comparator" nciodm:ExtCodeID="C116527">
                    <nciodm:CDISCSynonym>Sham Intervention</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A procedure or device that appears to be the same as the actual procedure or device being studied but does not contain active processes or components.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Sham Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Product Type Value Set Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Product Type Value Set Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Product Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C132309.Study Protocol Attribute Terminology" Name="Study Protocol Attribute Terminology" DataType="text" nciodm:ExtCodeID="C132309">
                <Description>
                    <TranslatedText xml:lang="en">A terminology value set relevant to the attributes of the study protocol entity.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Alternate Protocol Identifier" nciodm:ExtCodeID="C132344">
                    <nciodm:CDISCDefinition>A unique code assigned by an affiliated governing body or other organization that identifies a specific protocol (e.g., grant number, national number).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Alternate Protocol Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Brief Protocol Title" nciodm:ExtCodeID="C132345">
                    <nciodm:CDISCSynonym>Abbreviated Protocol Title</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The short descriptive name for the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Brief Protocol Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Official Protocol Title" nciodm:ExtCodeID="C132346">
                    <nciodm:CDISCDefinition>The formal descriptive name for the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Official Protocol Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Amendment" nciodm:ExtCodeID="C132347">
                    <nciodm:CDISCDefinition>A written description of a change(s) to, or formal clarification of, a protocol. (ICH E6)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Author" nciodm:ExtCodeID="C51853">
                    <nciodm:CDISCDefinition>A person who is the writer of a structured research study protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Author</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Synopsis" nciodm:ExtCodeID="C115628">
                    <nciodm:CDISCSynonym>Protocol Scientific Summary</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A scientific summary of the key points of the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Protocol Synopsis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Public Protocol Title" nciodm:ExtCodeID="C94105">
                    <nciodm:CDISCDefinition>The descriptive name of the protocol that is intended for the lay public, written in easily understood language.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Document Version Public Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Registry Protocol Identifier" nciodm:ExtCodeID="C132348">
                    <nciodm:CDISCDefinition>A unique code assigned by a clinical trial registry that identifies a specific protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Registry Protocol Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Schedule of Activities" nciodm:ExtCodeID="C132349">
                    <nciodm:CDISCSynonym>Schedule of Events</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>SoA</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A standardized representation of planned clinical trial activities including interventions (e.g., administering drug, surgery) and study administrative activities (e.g., obtaining informed consent, distributing clinical trial material and diaries, randomization) as well as assessments. (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Schedule of Activities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Scientific Protocol Title" nciodm:ExtCodeID="C132350">
                    <nciodm:CDISCDefinition>A more extensive descriptive name of the protocol that is intended for medical professionals, written using medical and scientific language.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Scientific Protocol Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Protocol Identifier" nciodm:ExtCodeID="C132351">
                    <nciodm:CDISCSynonym>Sponsor Protocol Code</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Sponsor Protocol Number</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A unique code assigned by the sponsor that identifies a specific protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Sponsor Protocol Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Acronym" nciodm:ExtCodeID="C94108">
                    <nciodm:CDISCSynonym>Trial Acronym</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A word or words formed from the beginning letters or a combination of syllables and letters of a compound term, which identifies a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Acronym</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol Version Approval by Oversight Committee Date" nciodm:ExtCodeID="C181245">
                    <nciodm:CDISCDefinition>The date on which a version of the protocol was finalized or approved by the study oversight committee.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Approval by Oversight Committee Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol Version Approval by Sponsor Date" nciodm:ExtCodeID="C132352">
                    <nciodm:CDISCSynonym>Protocol Amendment Approval by Sponsor Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Protocol Version Approval Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The date on which a version of the protocol was finalized or approved by the sponsor.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Approval by Sponsor Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Study Protocol Version" nciodm:ExtCodeID="C93490">
                    <nciodm:CDISCDefinition>A plan at a particular point in time for a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. (BRIDG)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Protocol Attribute Terminology</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Protocol Attribute Terminology</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Entities Study Protocol Attribute Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C147067.Study Purpose Value Set" Name="Study Purpose Value Set" DataType="text" nciodm:ExtCodeID="C147067">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the reason(s) or intention(s) for the execution of an interventional or non-interventional clinical study.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Basic Science" nciodm:ExtCodeID="C15714">
                    <nciodm:CDISCSynonym>Basic Research</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Basic Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Device Feasibility" nciodm:ExtCodeID="C139174">
                    <nciodm:CDISCDefinition>An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Device Feasibility Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Diagnosis" nciodm:ExtCodeID="C15220">
                    <nciodm:CDISCSynonym>Diagnostic</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results or summary of such an investigation. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Diagnosis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Exploratory Research" nciodm:ExtCodeID="C147146">
                    <nciodm:CDISCDefinition>Any action or process to perform research on a hypothetical or theoretical idea in order to determine whether the phenomena is new (which may lead to additional studies) or can be explained by an existing and well-substantiated theory. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Exploratory Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Health Services Research" nciodm:ExtCodeID="C15245">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Health Services Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Hypothesis Generation" nciodm:ExtCodeID="C147147">
                    <nciodm:CDISCDefinition>Any action or process to create a tentative proposal to explain certain observations or facts, and which requires further investigation to be verified. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Hypothesis Generation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Prevention" nciodm:ExtCodeID="C15843">
                    <nciodm:CDISCSynonym>Prophylaxis</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any action or response to modify or stop the development of a disease.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Preventive Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Screening" nciodm:ExtCodeID="C15419">
                    <nciodm:CDISCDefinition>Any action or process to identify a condition, or risk factors for a condition, in humans who are not yet known to have the condition or risk factor. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Disease Screening</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Supportive Care" nciodm:ExtCodeID="C15747">
                    <nciodm:CDISCDefinition>Any action or process to maximize comfort, minimize side effects, or mitigate against a decline in the participant's health or function. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Supportive Care</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Treatment" nciodm:ExtCodeID="C70742">
                    <nciodm:CDISCDefinition>Any action or process to improve or remedy a syndrome, disease, or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Treat</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>Study Purpose Value Set</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Purpose Value Set</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC Protocol Study Purpose Response Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C99077.STYPE" Name="Study Type Response" DataType="text" nciodm:ExtCodeID="C99077" nciodm:CodeListExtensible="No">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the role the study plays in determining the interventions a subject receives.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="EXPANDED ACCESS" nciodm:ExtCodeID="C98722">
                    <nciodm:CDISCDefinition>Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access studies include individual-patient IND, treatment IND, compassionate use, emergency use or continued access.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Expanded Access Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="INTERVENTIONAL" nciodm:ExtCodeID="C98388">
                    <nciodm:CDISCDefinition>Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Interventional Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSERVATIONAL" nciodm:ExtCodeID="C16084">
                    <nciodm:CDISCDefinition>Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PATIENT REGISTRY" nciodm:ExtCodeID="C129000">
                    <nciodm:CDISCDefinition>Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Patient Registry Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>STYPE</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Study Type Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Study Type Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C66736.TINDTP" Name="Trial Intent Type Response" DataType="text" nciodm:ExtCodeID="C66736" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the responses for the planned purpose of the therapy, device, or agent under study in the clinical trial.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="BASIC SCIENCE" nciodm:ExtCodeID="C15714">
                    <nciodm:CDISCSynonym>Basic Research</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Basic Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CURE" nciodm:ExtCodeID="C49654">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate intervention(s) aimed to cure a disease or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Cure Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DEVICE FEASIBILITY" nciodm:ExtCodeID="C139174">
                    <nciodm:CDISCDefinition>An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Device Feasibility Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DIAGNOSIS" nciodm:ExtCodeID="C49653">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Diagnosis Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DISEASE MODIFYING" nciodm:ExtCodeID="C170629">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the effects of treatment(s) intended to cause a change in disease, syndrome, or condition beyond the point of treatment administration.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Disease Modifying Treatment Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="HEALTH SERVICES RESEARCH" nciodm:ExtCodeID="C15245">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Health Services Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="MITIGATION" nciodm:ExtCodeID="C49655">
                    <nciodm:CDISCDefinition>A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Adverse Effect Mitigation Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PREVENTION" nciodm:ExtCodeID="C49657">
                    <nciodm:CDISCSynonym>Prophylaxis Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Prevention Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SCREENING" nciodm:ExtCodeID="C71485">
                    <nciodm:CDISCDefinition>A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Screening Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SUPPORTIVE CARE" nciodm:ExtCodeID="C71486">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Supportive Care Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TREATMENT" nciodm:ExtCodeID="C49656">
                    <nciodm:CDISCSynonym>Therapy Trial</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Treatment Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>TINDTP</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Trial Intent Type Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Trial Indication Type Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C66737.TPHASE" Name="Trial Phase Response" DataType="text" nciodm:ExtCodeID="C66737" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the phase, or stage, of the clinical trial.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="NOT APPLICABLE" nciodm:ExtCodeID="C48660">
                    <nciodm:CDISCSynonym>NA</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Not Applicable</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Determination of a value is not relevant in the current context. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Not Applicable</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE 0 TRIAL" nciodm:ExtCodeID="C54721">
                    <nciodm:CDISCSynonym>0</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Pre-clinical Trial</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 0</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>First-in-human trials, in a small number of subjects, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include any drug delivery but may be an exploration of human material from a study (e.g., tissue samples or biomarker determinations). [Improving the Quality of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington, DC, Oct 2007)] (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase 0 Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE I TRIAL" nciodm:ExtCodeID="C15600">
                    <nciodm:CDISCSynonym>1</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 1</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase I Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE I/II TRIAL" nciodm:ExtCodeID="C15693">
                    <nciodm:CDISCSynonym>1-2</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 1-2</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase I/II Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE II TRIAL" nciodm:ExtCodeID="C15601">
                    <nciodm:CDISCSynonym>2</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 2</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase II Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE II/III TRIAL" nciodm:ExtCodeID="C15694">
                    <nciodm:CDISCSynonym>2-3</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 2-3</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase II/III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE IIA TRIAL" nciodm:ExtCodeID="C49686">
                    <nciodm:CDISCSynonym>2A</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 2A</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase IIa Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE IIB TRIAL" nciodm:ExtCodeID="C49688">
                    <nciodm:CDISCSynonym>2B</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 2B</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase IIb Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE III TRIAL" nciodm:ExtCodeID="C15602">
                    <nciodm:CDISCSynonym>3</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 3</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE IIIA TRIAL" nciodm:ExtCodeID="C49687">
                    <nciodm:CDISCSynonym>3A</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 3A</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase IIIa Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE IIIB TRIAL" nciodm:ExtCodeID="C49689">
                    <nciodm:CDISCSynonym>3B</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 3B</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase IIIb Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE IV TRIAL" nciodm:ExtCodeID="C15603">
                    <nciodm:CDISCSynonym>4</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 4</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase IV Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHASE V TRIAL" nciodm:ExtCodeID="C47865">
                    <nciodm:CDISCSynonym>5</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Phase 5</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Postmarketing surveillance is sometimes referred to as Phase V.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Phase V Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>TPHASE</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Trial Phase Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Trial Phase Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C66739.TTYPE" Name="Trial Type Response" DataType="text" nciodm:ExtCodeID="C66739" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">A terminology codelist relevant to the type of primary outcome or endpoint that the protocol is designed to evaluate.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="ADHESION PERFORMANCE" nciodm:ExtCodeID="C158283">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the strength of the bond between an adhesive and the application surface.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Adhesion Performance Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ALCOHOL EFFECT" nciodm:ExtCodeID="C158284">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the effects of alcohol on investigational product safety and/or efficacy.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Alcohol Effect Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BIO-AVAILABILITY" nciodm:ExtCodeID="C49664">
                    <nciodm:CDISCDefinition>A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Bioavailability Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BIO-EQUIVALENCE" nciodm:ExtCodeID="C49665">
                    <nciodm:CDISCDefinition>A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Therapeutic Equivalency Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BIOSIMILARITY" nciodm:ExtCodeID="C158288">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate whether a biologic test article is highly similar in function and effect to an existing biologic that has already been clinically tested and approved for use.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biosimilarity Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DEVICE-DRUG INTERACTION" nciodm:ExtCodeID="C158285">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the interaction between a device and a drug, where the use of one may affect the disposition, function, efficacy, or safety of the other.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Device-Drug Interaction Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DIAGNOSIS" nciodm:ExtCodeID="C49653">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Diagnosis Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSE FINDING" nciodm:ExtCodeID="C158289">
                    <nciodm:CDISCDefinition>An early phase clinical study with the objective of determining the optimal dose of an investigational product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose Finding Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSE PROPORTIONALITY" nciodm:ExtCodeID="C158290">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the relationship between dose and resulting exposure.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose Proportionality Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSE RESPONSE" nciodm:ExtCodeID="C127803">
                    <nciodm:CDISCDefinition>A study of the effect of dose changes on the efficacy of a drug in order to determine the dose-response relationship and optimal dose of a therapy.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose Response Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DRUG-DRUG INTERACTION" nciodm:ExtCodeID="C158286">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the interaction between drugs, where the use of one may affect the disposition, efficacy, or safety of the other.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Drug-Drug Interaction Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ECG" nciodm:ExtCodeID="C178057">
                    <nciodm:CDISCSynonym>Electrocardiographic Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Electrocardiographic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EFFICACY" nciodm:ExtCodeID="C49666">
                    <nciodm:CDISCDefinition>A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Efficacy Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FOOD EFFECT" nciodm:ExtCodeID="C98729">
                    <nciodm:CDISCDefinition>Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Food Effect Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="IMMUNOGENICITY" nciodm:ExtCodeID="C120842">
                    <nciodm:CDISCDefinition>A study that assesses an agent's ability to provoke an immune response.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Immunogenicity Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHARMACODYNAMIC" nciodm:ExtCodeID="C49662">
                    <nciodm:CDISCDefinition>A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacodynamic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHARMACOECONOMIC" nciodm:ExtCodeID="C39493">
                    <nciodm:CDISCDefinition>A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacoeconomic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHARMACOGENETIC" nciodm:ExtCodeID="C129001">
                    <nciodm:CDISCDefinition>A study that assesses variation in DNA sequence, usually within a single gene, and its effect on drug response.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacogenetic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHARMACOGENOMIC" nciodm:ExtCodeID="C49661">
                    <nciodm:CDISCDefinition>A study that identifies or assesses variations within the entire genome, including DNA, RNA, or transcriptional elements, and its effects on drug response.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacogenomic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PHARMACOKINETIC" nciodm:ExtCodeID="C49663">
                    <nciodm:CDISCDefinition>A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacokinetic Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="POSITION EFFECT" nciodm:ExtCodeID="C161477">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the effect of body position during and/or after administration of the investigational product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Position Effect Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PREVENTION" nciodm:ExtCodeID="C49657">
                    <nciodm:CDISCSynonym>Prophylaxis Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Prevention Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="REACTOGENICITY" nciodm:ExtCodeID="C174366">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the expected, acute types of immunological responses, sometimes considered excessive, following agent administration.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Reactogenicity Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SAFETY" nciodm:ExtCodeID="C49667">
                    <nciodm:CDISCDefinition>A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Safety Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SWALLOWING FUNCTION" nciodm:ExtCodeID="C161478">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the effect of the investigational product on the physiologic act of swallowing.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Swallowing Function Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="THOROUGH QT" nciodm:ExtCodeID="C158287">
                    <nciodm:CDISCSynonym>TQT Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the ability of an investigational product and/or approved drug to delay cardiac ventricular repolarization as detected by QT prolongation and other ECG parameters.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Thorough QT Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TOLERABILITY" nciodm:ExtCodeID="C98791">
                    <nciodm:CDISCDefinition>A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Tolerability Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TREATMENT" nciodm:ExtCodeID="C49656">
                    <nciodm:CDISCSynonym>Therapy Trial</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Treatment Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="USABILITY TESTING" nciodm:ExtCodeID="C161479">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the user experience with a product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Usability Testing Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="WATER EFFECT" nciodm:ExtCodeID="C161480">
                    <nciodm:CDISCDefinition>A type of study designed to evaluate the effects of water on investigational product safety and/or efficacy.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Water Effect Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>TTYPE</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Trial Type Response</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Trial Type Terminology</nciodm:PreferredTerm>
            </CodeList>
        </MetaDataVersion>
    </Study>
</ODM>
